Brown Advisory Inc Coherus Bio Sciences, Inc. Transaction History

Brown Advisory Inc

$77.3 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 29, 2021	SELL	$12.95 - $15.41 $3.59 Million - $4.28 Million	-277,471 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$14.42 - $21.39 $3.71 Million - $5.5 Million	257,099 Added 1262.02%	277,471 $4.05 Million
Q4 2020 Feb 12, 2021	SELL	$16.56 - $18.94 $13.8 Million - $15.8 Million	-835,296 Reduced 97.62%	20,372 $354,000
Q3 2020 Nov 16, 2020	BUY	$17.41 - $19.89 $862,735 - $985,629	49,554 Added 6.15%	855,668 $15.7 Million
Q2 2020 Aug 14, 2020	BUY	$14.43 - $19.16 $648,801 - $861,471	44,962 Added 5.91%	806,114 $14.4 Million
Q1 2020 May 15, 2020	BUY	$11.67 - $22.53 $91,212 - $176,094	7,816 Added 1.04%	761,152 $12.3 Million
Q4 2019 Feb 14, 2020	BUY	$16.33 - $21.37 $384,375 - $503,007	23,538 Added 3.23%	753,336 $13.6 Million
Q3 2019 Nov 14, 2019	BUY	$16.3 - $23.37 $1.2 Million - $1.71 Million	73,343 Added 11.17%	729,798 $14.8 Million
Q2 2019 Aug 12, 2019	BUY	$13.1 - $22.1 $40,099 - $67,648	3,061 Added 0.47%	656,455 $14.5 Million
Q1 2019 May 15, 2019	SELL	$8.38 - $15.5 $148,401 - $274,489	-17,709 Reduced 2.64%	653,394 $8.91 Million
Q4 2018 Feb 13, 2019	BUY	$8.65 - $16.28 $102,390 - $192,706	11,837 Added 1.8%	671,103 $6.07 Million
Q3 2018 Nov 13, 2018	BUY	$14.45 - $20.25 $364,457 - $510,745	25,222 Added 3.98%	659,266 $10.9 Million
Q2 2018 Aug 10, 2018	SELL	$10.25 - $17.45 $40,313 - $68,630	-3,933 Reduced 0.62%	634,044 $8.88 Million
Q1 2018 Jun 28, 2018	BUY	$9.1 - $13.7 $2.5 Million - $3.76 Million	274,811 Added 75.67%	637,977 $7.05 Million
Q1 2018 May 14, 2018	SELL	$9.1 - $13.7 $2.46 Million - $3.7 Million	-269,869 Reduced 42.63%	363,166 $4.01 Million
Q4 2017 Feb 12, 2018	BUY	$8.35 - $14.4 $325,766 - $561,801	39,014 Added 6.57%	633,035 $5.57 Million
Q3 2017 Nov 13, 2017	BUY	$11.1 - $14.5 $346,442 - $452,559	31,211 Added 5.55%	594,021 $7.93 Million
Q2 2017 Aug 14, 2017	BUY	N/A	562,810	562,810 $8.08 Million

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

Black Rock Inc. New York, NY

11.8M
Shares

$12.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.3M
Shares

$12.3 Million
0.0% of portfolio
Rubric Capital Management LP New York, NY

10.4M
Shares

$11.3 Million
0.3% of portfolio
Kohlberg Kravis Roberts & Co. L.P. New York, NY

3.04M
Shares

$3.31 Million
0.18% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

2.86M
Shares

$3.11 Million
0.0% of portfolio

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $84.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Account